Relevant and even prescient commentary on news, politics and the economy.

Pharmacy Benefit Managers: The Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies

There are seventy-one pages to this FTC report. My commentary looks at 5 edited (mine) pages of the report. The intent is to introduce you to Pharmacy Benefit Managers (PBMs) and the control they have over the market. The services they provide has been integrated with the healthcare insurance companies. Which makes this a dynamic […]

Generic drugs reimbursement is an issue identified by the Senate Finance Committee

AB: This brief article gets right down to the basics in where costs are added and impacting the prices to the consumer. It is simple and straight to the point of how PBMs impact the prices to the consumer. Very little or nothing was contributed by myself to this article by the authors Inmaculada Hernandez; […]

Seeking the reasons for the death for HB 135

This is Part 1 of a three-part story of how politics and delays backed by commercial interests and business sponsor groups delayed and eventually killed a bill meant to aid Ohio citizens. Kind of a forerunner to what may happen if Congress ever promotes a bill for healthcare-for-all. I will post the other two parts […]

SCOTUS: States Can Regulate Insurance Plan Contractors

While briefly discussing (accessible link below for addition information) this decision, keep in mind this is a big deal in lowering the costs of pharmaceuticals as it goes right to the source of some of the excess takings involved in the distribution of drugs from manufacturer to drug stores. December 10, 2020: the Supreme Court […]